Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma

Urology

Volumn 59, Issue 4, 2002, Pages 615-620

  Uchida, Toyoaki ^a   Gao, Jiang Ping ^a   Wang, Chunxi ^a   Jiang, Shi Xu ^a   Muramoto, Masatoshi ^a   Satoh, Takefumi ^a   Minei, Sadanori ^a   Shimura, Satoru ^a   Irie, Akira ^a   Kameya, Toru ^a   Baba, Shiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CLINICAL RESEARCH; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036129145     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01601-6     Document Type: Article

References (28)

1. Mutations with p53 tumor suppressor gene; clues to cancer etiology and molecular pathogenesis
2. Structure and function of the p53 tumor suppressor gene; clues for rational cancer therapeutic strategies
3. Braking the cycle
4. Mdm2; 'big brother' of p53
5. mdm2-master regulator of the p53 tumor suppressor protein
6. The mdm2 gene amplification database
7. Molecular the apoptosis; a discourse on the bcl-2 family and cell death
8. Down-regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues
9. bcl-2 and the regulation of programmed cell death
10. Systemic therapy for renal cell carcinoma
11. p53 mutations and mdm2 amplification in renal cell cancers
12. p53 protein expression but not mdm2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma
13. mdm2 expression as a prognostic indicator in clear cell carcinoma comparison with p53 overexpression and clinicopathological parameters
14. Relationship between p53 gene mutation and protein expression; clinical significance in transitional cell carcinoma of the bladder
15. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism
16. Infrequent involvement of p53 mutation and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma
17. Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma
18. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinoma
19. Frequent expression of bcl-2 in renal cell carcinoma carrying wild-type p53
20. p53, bcl-2, and Bax expression in renal cell carcinoma
21. Expression of Bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma
22. Immunohistochemical expression of p53 and bcl-2 proteins is not associated with sarcomatoid change in renal cell carcinoma
23. Prognostic factors in renal cell carcinoma; immunohistochemical detection of p53 protein versus clinico-pathological parameters
24. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas; no evidence for prognostic significance
25. Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma
26. Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein bcl-2 and c-myc have no independent prognostic value in renal adenocarcinoma
27. Immunohistochemical analysis of bcl-2 protein expression in renal cell carcinoma